sb 216763 has been researched along with Disease Exacerbation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jung, DB; Jung, JH; Kang, SE; Kim, H; Kim, SH; Lee, H; Srivastava, SK; Yun, M | 1 |
Gao, JF; Huang, XY; Jing, SF; Li, CD; Wang, DZ; Wei, H | 1 |
2 other study(ies) available for sb 216763 and Disease Exacerbation
Article | Year |
---|---|
Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7.
Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Cysteine Proteinase Inhibitors; Disease Progression; F-Box-WD Repeat-Containing Protein 7; G1 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Glycogen Synthase Kinase 3 beta; HCT116 Cells; HEK293 Cells; HT29 Cells; Humans; Indoles; Leupeptins; Male; Maleimides; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Phosphorylation; Proto-Oncogene Proteins c-myc; Repressor Proteins; RNA Interference; RNA, Small Interfering; Transplantation, Heterologous | 2018 |
Antitumor Effect of Docetaxel in Osteosarcoma by the Inhibition of Wnt Signal Channel.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Maleimides; Matrix Metalloproteinase 9; Osteosarcoma; Taxoids; Time Factors; Wnt Signaling Pathway | 2015 |